Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer
Published in: Breast Cancer 1/2009

01-01-2009 | Special Feature

Ultrasound screening of breast cancer

Authors: Eriko Tohno, Ei Ueno, Hiroshi Watanabe

Published in: Breast Cancer | Issue 1/2009

Login to get access

Abstract

Ultrasound (US) screening of breast cancer was surveyed with the results of breast screening combined with mammography (MMG), US and clinical breast examination (CBE) at Ibaraki Health Service Association. Breast cancer is common among women in their late 40s in Japan, who tend to have small and dense breasts. Our results showed that US works as well as MMG in detecting breast cancers in women in their 40s, and both modalities are compensatory. There are many reports that the combination of MMG and US is a suitable method for breast screening in Japan. A large-scale randomized control trial is now ongoing to investigate whether breast screening by both MMG and US is useful to decrease breast cancer mortality.
Literature
1.
Izuo M. Memorial address of the 10th annual meeting. The History of breast cancer screening in Japan. J Jpn Assoc Breast Cancer Screen. 2001;10:3–16.
2.
Kikuchi K, Tanaka K, Wagai T. Early cancer diagnosis through ultrasonics. J Acoust Soc Am. 1957;29:824–33.
3.
Takahashi K, Nishimura S, Tada K, Makita M, Tada T, Yoshimoto M, et al. Palpable breast cancers that are undetectable by mammography: The importance of palpation in breast cancer screening. J Jpn Assoc Breast Cancer Screen. 2003;12:163–8.
4.
Koike Y, Terai N. A comparative study of diagnostic accuracy rate and unimaged rate of mammography for breast cancer. J Jpn Surg Assoc. 2001;62:2102–9.
5.
Yanagida Y, Koida T, Kimura M, Tamaki Y, Horikoshi H, Higuchi K, et al. Diangosis of invasive breast cancer whose size is 1 cm or less (in Japanese, no English abstract). Nyugan no Rinsho. 2003;18:484–5.
6.
Tunoda H, Tohno E, Ueno E, Aiyoshi Y, Yashiro T, Hara H, et al. Examination of effectiveness of breast cancer detection by modalities and age groups. J Jpn Assoc Breast Cancer Screen. 1998;7:281–5.
7.
Osako T, Takahashi K, Iwase T, Iijima K, Miyagi Y, Nishimura S, et al. Diagnostic ultrasonography and mammography for invasive and noninvasive breast cancer in women aged 30 to 39 years. Breast Cancer. 2007;14:229–33.PubMedCrossRef
8.
9.
Hasegawa S, Ohnuki K, Nagakubo J, Kitami A, Oyama K, Koizumi R, et al. Breast cancer imaging by mammography: effects of age and breast composition. J Jpn Assoc Breast Cancer Screen. 2003;12:101–7.
10.
Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, et al. For the American Cancer Society breast cancer advisory group, “American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography”. CA Cancer J Clin. 2007;57:75–89.PubMedCrossRef
11.
Hamada I, Nasu S, Yoshimura R, Yoshimoto M, Koga S, Watanabe R. Results of breast cancer screening with mammography and ultrasonography in a health check-up organization. Ningen Doq. 2006;21:32–6.
12.
Takebe K, Nakamura K, Misao T. Usefulness of whole-breast scanning by physicians in mass breast-cancer screening of young women. J Jpn Assoc Breast Cancer Screen. 2000;9:155–60.
13.
Hirokaga T, Namba K, Watanabe R, Furusawa H, Matsunaga T, Namba S. Effectiveness of evaluation of breast cancer screening using ultrasound combined with mammography. J Jpn Assoc Cancer Detect Diagn. 2004;11:131–5.
14.
Yamasaki M, Nasu S, Koga S, Mori H. Detection rate of breast cancer by mammography and ultrasonography screening in women aged between 40 and 49. J Jpn Assoc Breast Cancer Screen. 2002;11:265–9.
15.
Maruyama M, Ooba S, Uchida K, Kamiya K, Aritomi H. Breast cancer screening by both mammography and ultrasound is recommended for women aged 40–49 y in Japan. J Jpn Assoc Breast Cancer Screen. 2000;9:161–5.
16.
Czyzewski A. Ultrasound should be added to breast cancer screening for at-risk women. JAMA. 2008;299:2151–63.CrossRef
17.
Tohno E, Ide S, Shibata K, Kujiraoka Y, Koseki E. Occurrence of focal detection abnormalities in breast cancer screening by ultrasound. J Jpn Assoc Breast Cancer Screen. 2000;9:231–6.
18.
Japan Association of Breast and Thyroid Sonology ed. Guideline for breast ultrasound—management and diagnosis, 2nd ed. Nankodo Co. Ltd., Tokyo 2008. p. 103–13.
19.
Tohno E, Sawai K, Shimamoto K, Ueno E, Endou T, Tsunoda-Shimizu H, et al. Establishment of Seminars to improve the diagnostic accuracy and effectiveness of breast ultrasound. J Med Ultrasonics. 2006;33:239–44.CrossRef
Metadata
Title
Ultrasound screening of breast cancer
Authors
Eriko Tohno
Ei Ueno
Hiroshi Watanabe
Publication date
01-01-2009
Publisher
Springer Japan
Published in
Breast Cancer / Issue 1/2009
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-008-0082-8

Other articles of this Issue 1/2009

Breast Cancer 1/2009 Go to the issue

Original Article

Comparison of reading time between screen-film mammography and soft-copied, full-field digital mammography

Special Feature

Current status of breast cancer screening in the world

Original Article

Whole-breast volume perfusion images using 256-row multislice computed tomography: visualization of lesions with ductal spread

Case Report

Axillary mass suspected to be occult breast carcinoma: a case study of skipped axillary lymph node metastasis from endometrial carcinoma in which core-needle biopsy was useful for diagnosis

Case Report

Successful treatment of leptomeningeal metastases from breast cancer using the combination of trastuzumab and capecitabine: a case report

Case Report

Indeterminate calcification and clustered cystic lesions are strongly predictive of the presence of mucocele-like tumor of the breast: a report of six cases
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits